Rising Dragon Acquisition Corp. (RDAC) 股票分析
金融服务Rising Dragon Acquisition Corp.
$9.38
$-0.31 (-3.20%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
Rising Dragon Acquisition Corp. operates primarily as a shell company with no significant operational business, focusing exclusively on executing business combinations such as mergers, share exchanges, asset acquisitions, or recapitalizations with one or more external entities. The company is classified within the Financial Services sector and specifically under the Shell Companies industry, a designation that reflects its transitional status as a vehicle designed to seek a target for merger rather than engaging in ongoing commercial production. Its current market capitalization stands at $32.73M, while its annual revenue is not available in the provided financial data, and the number of employees is listed as N/A, indicating a lack of substantial operational workforce. These valuation and scale metrics suggest that the firm exists primarily as a financial instrument awaiting a special situation transaction, rather than as a traditional operating enterprise with established revenue streams or a large employee base to support ongoing service delivery.
财务健康
The reported net income for the trailing twelve months is $1.57M, while revenue and EBITDA figures are not available, creating a financial picture where profitability exists without disclosed top-line activity or earnings before interest, taxes, depreciation, and amortization. Although a positive net income is recorded, the absence of revenue data prevents a direct calculation of margins based on sales, yet the company reports a gross margin of 0.0%, an operating margin of 0.0%, and a profit margin of 0.0%, which collectively indicate that the company's current financial structure does not generate profit from core operations or sales activities in the traditional sense. The company reports a free cash flow of $-354,743, signaling a net cash outflow that constrains financial flexibility and suggests ongoing expenditures that are not being covered by operating cash generation. On the balance sheet, the company holds $37,174 in cash against $304,969 in debt, resulting in a leverage position where liabilities significantly exceed liquid assets, and the debt-to-equity ratio is listed as N/A due to the specific accounting treatment of the shell structure. The current ratio is 0.09, a figure that indicates severe short-term liquidity stress, meaning the company possesses less than one-tenth of the liquid assets required to cover its current liabilities without external financing. Return on Equity is listed as N/A, while Return on Assets stands at -1.0%, revealing that the company's asset base is currently generating a negative return relative to the equity invested, which points to inefficiency in capital deployment typical of a pre-transaction entity.
估值评估
The trailing twelve-month P/E ratio is 26.19, whereas the forward P/E is N/A, a discrepancy that implies the market is currently pricing in earnings that have not yet been projected for the future, likely due to the absence of expected earnings growth in a shell company context. The price-to-book ratio is reported as -21.07, a negative figure that indicates the market capitalization is valued significantly below the book value of equity, reflecting the intangible nature of the company's assets and its status as a special purpose acquisition vehicle rather than an asset-heavy operation. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are both N/A, suggesting that traditional multiples used to value operating companies are inapplicable given the lack of sales data and unadjusted earnings before interest, taxes, depreciation, and amortization. The stock has traded between a 52-week low of $4.59 and a 52-week high of $16.43, with the current price position dependent on real-time market fluctuations which are not specified in the provided facts, but the wide range demonstrates significant historical volatility. The beta value is N/A, indicating that standard market volatility comparisons relative to the broader index cannot be calculated for this specific security, further distinguishing its risk profile from that of established operating companies.
Growth & Income
Revenue growth year-over-year and earnings growth year-over-year are both listed as N/A or -79.1% respectively, where the earnings growth figure of -79.1% indicates a sharp contraction in profitability, though the lack of revenue growth data prevents a definitive comparison of operational scaling. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that all available earnings are theoretically available for reinvestment or retention within the shell structure rather than being distributed to shareholders. Because the company does not distribute income via dividends, any potential future value creation would rely entirely on the successful execution of a business combination rather than the payout of cash returns to investors. The overall growth and income profile is characterized by a lack of historical earnings expansion and a complete absence of dividend income, positioning the security strictly as a speculative vehicle dependent on future merger activity rather than current operational performance or shareholder yield.
同行比较
Rising Dragon Acquisition Corp. (RDAC) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| Rising Dragon Acquisition Corp. | RDAC | $57.67M | 51.0 |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。Rising Dragon Acquisition Corp.的市盈率为51.0。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于Rising Dragon Acquisition Corp.
Rising Dragon Acquisition Corp. does not have significant operations. It focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2024 and is based in Taiyuan, the People's Republic of China.
公司简介以英文显示。